Apollomics Inc.

APLM | NASDAQ

Price Alert Chart Builder DCF Calculator

$23.91

+$0.49 (+2.09%)

At close: Sep 21, 2026, 4:00 PM ET

$23.95

+$0.04 (+0.17%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.09%

(1D)

Rating

Updated: Aug 24, 2026

34.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $52.51M

1D Range

23.43 25

52W Range

10.01 42.12

Valuation (TTM)

PE -3.16

PB -16.47

EV/EBITDA -5.26

Valuation (NTM)

Forward PE N/A

Forward PEG -0.24

Price Target N/A

Cash Flow

FCF Yield -19.8%

SBC Adj. FCF Yield -17.9%

SBC Impact -9.4%

Margins

Gross Margin 100.0%

Operating Margin -111.5%

FCF Margin -122.0%

Growth (CAGR)

Revenue 3Y | 5Y 136.7% | 35.8%

Dil EPS 3Y | 5Y -77.7% | 5.4%

FCF 3Y | 5Y 59.8% | 23.8%

Returns

ROA -162.9%

ROE 288.4%

ROIC -1586.8%

Financial Health

Net Cash

$3.28M

Current Ratio 0.96

Interest Coverage -145.74

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Apollomics, Inc., a biotechnology enterprise established in 2015 and headquartered in Foster City, California, conducts its research and development operations across California, Hangzhou, Shanghai, C...

Sector Healthcare

Industry Biotechnology

Employees 14

IPO Date Nov 25, 2021

Website www.apollomicsinc.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.